We developed a highly sensitive enzyme immunoassay (EIA) for measuring lgG and 1gM antibodies against human skeletal muscle (SM) component and tested sera from 100 patients with myasthenia gravis (MG), 59 with thymoma and 41 without thymoma. We found that the frequency of anti-SM lgG antibodies was significantly higher in MG patients with (81%) than without (37%) thymoma. The titers of the anti-SM lgG antibodies measured by EIA correlated well with those measured by AlA (r = 0.81, P <0.01).
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We developed a highly sensitive enzyme immunoassay (EIA) for measuring lgG and 1gM antibodies against human skeletal muscle (SM) component and tested sera from 100 patients with myasthenia gravis (MG), 59 with thymoma and 41 without thymoma. We found that the frequency of anti-SM lgG antibodies was significantly higher in MG patients with (81%) than without (37%) thymoma. The titers of the anti-SM lgG antibodies measured by EIA correlated well with those measured by AlA (r = 0.81, P <0.01).
We also found that 12% of the myasthenic patients with thymoma and 15% 
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